LymphedemaV1, PascalFrancis, Corpus, bibRecord, 000427

Interstitial MR lymphangiography : A diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema

Identifieur interne : 000427 ( PascalFrancis/Corpus ); précédent : 000426; suivant : 000428

Interstitial MR lymphangiography : A diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema

Auteurs : Christian Lohrmann ; Etelka Foeldi ; Jean-Paul Bartholom ; Mathias Langer

Source :

Acta tropica [ 0001-706X ] ; 2007.

RBID : Pascal:07-0502672

Descripteurs français

Pascal (Inist)
- Imagerie RMN, Lymphoedème, Diagnostic, Méthodologie, Evaluation, Homme, Malade, Stade avancé, Médecine tropicale.

English descriptors

KwdEn :
- Advanced stage, Diagnosis, Evaluation, Human, Lymphedema, Methodology, Nuclear magnetic resonance imaging, Patient, Tropical medicine.

Abstract

Background: To assess the feasibility of interstitial magnetic resonance lymphangiography with intracutaneous injection of a commercially available, non-ionic, extracellular paramagnetic contrast agent, to visualize lymphatic vessels in patients with clinically advanced stages of primary lymphedema. Methods: Sixteen lower extremities in 8 patients with clinically advanced stages of primary lymphedema were examined with magnetic resonance lymphangiography. A 18 mL of gadodiamide and 2 mL of mepivacainhydrochloride 1% were subdivided into 10 portions and injected intracutaneously into the dorsal aspect of both feet. For MRL, a 3D spoiled gradient-echo sequence (Volumetric Interpolated Breathold Examination, VIBE) was performed. Results: The beaded appearance of lymphatic vessels extending from the injection site was detected in all 16 lower extremities (100%). In 10 lower extremities (63%), lymphatic vessels of the upper leg could be visualized. A contrast enhancement was observed in 10/16 inguinal lymph node groups (63%). In 12 lower extremities (75%) collateral vessels with dermal back-flow areas between lymphatic vessels were seen. Conclusion: Magnetic resonance lymphangiography is safe, technically feasible, and assists the clinician in the therapeutic planning of patients with clinically advanced stages of primary lymphedema by imaging the pathologically modified lymphatic vessels and accompanying complications non-invasively.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0001-706X`
A02	`01`			`@0 ACTRAQ`
A03		`1`		`@0 Acta trop.`
A05				`@2 104`
A06				`@2 1`
A08	`01`	`1`	`ENG`	`@1 Interstitial MR lymphangiography : A diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema`
A11	`01`	`1`		`@1 LOHRMANN (Christian)`
A11	`02`	`1`		`@1 FOELDI (Etelka)`
A11	`03`	`1`		`@1 BARTHOLOMÄ (Jean-Paul)`
A11	`04`	`1`		`@1 LANGER (Mathias)`
A14	`01`			`@1 Division of Diagnostic Radiology, Department of Radiology, University Hospital of Freiburg, Hugstetter Strasse 55 @2 79106 Freiburg @3 DEU @Z 1 aut. @Z 3 aut. @Z 4 aut.`
A14	`02`			`@1 Foeldi Clinic for Lymphology, Hinterzarten, Röβlehofweg 2-6 @2 79856 Hinterzarten @3 DEU @Z 2 aut.`
A20				`@1 8-15`
A21				`@1 2007`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 3165 @5 354000162004620020`
A44				`@0 0000 @1 © 2007 INIST-CNRS. All rights reserved.`
A45				`@0 1/2 p.`
A47	`01`	`1`		`@0 07-0502672`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Acta tropica`
A66	`01`			`@0 NLD`
C01	`01`		`ENG`	@0 Background: To assess the feasibility of interstitial magnetic resonance lymphangiography with intracutaneous injection of a commercially available, non-ionic, extracellular paramagnetic contrast agent, to visualize lymphatic vessels in patients with clinically advanced stages of primary lymphedema. Methods: Sixteen lower extremities in 8 patients with clinically advanced stages of primary lymphedema were examined with magnetic resonance lymphangiography. A 18 mL of gadodiamide and 2 mL of mepivacainhydrochloride 1% were subdivided into 10 portions and injected intracutaneously into the dorsal aspect of both feet. For MRL, a 3D spoiled gradient-echo sequence (Volumetric Interpolated Breathold Examination, VIBE) was performed. Results: The beaded appearance of lymphatic vessels extending from the injection site was detected in all 16 lower extremities (100%). In 10 lower extremities (63%), lymphatic vessels of the upper leg could be visualized. A contrast enhancement was observed in 10/16 inguinal lymph node groups (63%). In 12 lower extremities (75%) collateral vessels with dermal back-flow areas between lymphatic vessels were seen. Conclusion: Magnetic resonance lymphangiography is safe, technically feasible, and assists the clinician in the therapeutic planning of patients with clinically advanced stages of primary lymphedema by imaging the pathologically modified lymphatic vessels and accompanying complications non-invasively.
C02	`01`	`X`		`@0 002B01`
C02	`02`	`X`		`@0 002B12B04`
C03	`01`	`X`	`FRE`	`@0 Imagerie RMN @5 01`
C03	`01`	`X`	`ENG`	`@0 Nuclear magnetic resonance imaging @5 01`
C03	`01`	`X`	`SPA`	`@0 Imaginería RMN @5 01`
C03	`02`	`X`	`FRE`	`@0 Lymphoedème @5 02`
C03	`02`	`X`	`ENG`	`@0 Lymphedema @5 02`
C03	`02`	`X`	`SPA`	`@0 Linfedema @5 02`
C03	`03`	`X`	`FRE`	`@0 Diagnostic @5 09`
C03	`03`	`X`	`ENG`	`@0 Diagnosis @5 09`
C03	`03`	`X`	`SPA`	`@0 Diagnóstico @5 09`
C03	`04`	`X`	`FRE`	`@0 Méthodologie @5 10`
C03	`04`	`X`	`ENG`	`@0 Methodology @5 10`
C03	`04`	`X`	`SPA`	`@0 Metodología @5 10`
C03	`05`	`X`	`FRE`	`@0 Evaluation @5 11`
C03	`05`	`X`	`ENG`	`@0 Evaluation @5 11`
C03	`05`	`X`	`SPA`	`@0 Evaluación @5 11`
C03	`06`	`X`	`FRE`	`@0 Homme @5 12`
C03	`06`	`X`	`ENG`	`@0 Human @5 12`
C03	`06`	`X`	`SPA`	`@0 Hombre @5 12`
C03	`07`	`X`	`FRE`	`@0 Malade @5 13`
C03	`07`	`X`	`ENG`	`@0 Patient @5 13`
C03	`07`	`X`	`SPA`	`@0 Enfermo @5 13`
C03	`08`	`X`	`FRE`	`@0 Stade avancé @5 14`
C03	`08`	`X`	`ENG`	`@0 Advanced stage @5 14`
C03	`08`	`X`	`SPA`	`@0 Estadio avanzado @5 14`
C03	`09`	`X`	`FRE`	`@0 Médecine tropicale @5 15`
C03	`09`	`X`	`ENG`	`@0 Tropical medicine @5 15`
C03	`09`	`X`	`SPA`	`@0 Medicina tropical @5 15`
C07	`01`	`X`	`FRE`	`@0 Imagerie médicale @5 37`
C07	`01`	`X`	`ENG`	`@0 Medical imagery @5 37`
C07	`01`	`X`	`SPA`	`@0 Imaginería médica @5 37`
C07	`02`	`X`	`FRE`	`@0 Appareil circulatoire pathologie @5 38`
C07	`02`	`X`	`ENG`	`@0 Cardiovascular disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Aparato circulatorio patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Lymphatique pathologie @5 39`
C07	`03`	`X`	`ENG`	`@0 Lymphatic vessel disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Linfático patología @5 39`
N21				`@1 330`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 07-0502672 INIST
ET :	Interstitial MR lymphangiography : A diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema
AU :	LOHRMANN (Christian); FOELDI (Etelka); BARTHOLOMÄ (Jean-Paul); LANGER (Mathias)
AF :	Division of Diagnostic Radiology, Department of Radiology, University Hospital of Freiburg, Hugstetter Strasse 55/79106 Freiburg/Allemagne (1 aut., 3 aut., 4 aut.); Foeldi Clinic for Lymphology, Hinterzarten, Röβlehofweg 2-6/79856 Hinterzarten/Allemagne (2 aut.)
DT :	Publication en série; Niveau analytique
SO :	Acta tropica; ISSN 0001-706X; Coden ACTRAQ; Pays-Bas; Da. 2007; Vol. 104; No. 1; Pp. 8-15; Bibl. 1/2 p.
LA :	Anglais
EA :	Background: To assess the feasibility of interstitial magnetic resonance lymphangiography with intracutaneous injection of a commercially available, non-ionic, extracellular paramagnetic contrast agent, to visualize lymphatic vessels in patients with clinically advanced stages of primary lymphedema. Methods: Sixteen lower extremities in 8 patients with clinically advanced stages of primary lymphedema were examined with magnetic resonance lymphangiography. A 18 mL of gadodiamide and 2 mL of mepivacainhydrochloride 1% were subdivided into 10 portions and injected intracutaneously into the dorsal aspect of both feet. For MRL, a 3D spoiled gradient-echo sequence (Volumetric Interpolated Breathold Examination, VIBE) was performed. Results: The beaded appearance of lymphatic vessels extending from the injection site was detected in all 16 lower extremities (100%). In 10 lower extremities (63%), lymphatic vessels of the upper leg could be visualized. A contrast enhancement was observed in 10/16 inguinal lymph node groups (63%). In 12 lower extremities (75%) collateral vessels with dermal back-flow areas between lymphatic vessels were seen. Conclusion: Magnetic resonance lymphangiography is safe, technically feasible, and assists the clinician in the therapeutic planning of patients with clinically advanced stages of primary lymphedema by imaging the pathologically modified lymphatic vessels and accompanying complications non-invasively.
CC :	002B01; 002B12B04
FD :	Imagerie RMN; Lymphoedème; Diagnostic; Méthodologie; Evaluation; Homme; Malade; Stade avancé; Médecine tropicale
FG :	Imagerie médicale; Appareil circulatoire pathologie; Lymphatique pathologie
ED :	Nuclear magnetic resonance imaging; Lymphedema; Diagnosis; Methodology; Evaluation; Human; Patient; Advanced stage; Tropical medicine
EG :	Medical imagery; Cardiovascular disease; Lymphatic vessel disease
SD :	Imaginería RMN; Linfedema; Diagnóstico; Metodología; Evaluación; Hombre; Enfermo; Estadio avanzado; Medicina tropical
LO :	INIST-3165.354000162004620020
ID :	07-0502672

Links to Exploration step

Pascal:07-0502672

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Interstitial MR lymphangiography : A diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema</title>
<author><name sortKey="Lohrmann, Christian" sort="Lohrmann, Christian" uniqKey="Lohrmann C" first="Christian" last="Lohrmann">Christian Lohrmann</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Diagnostic Radiology, Department of Radiology, University Hospital of Freiburg, Hugstetter Strasse 55</s1>
<s2>79106 Freiburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Foeldi, Etelka" sort="Foeldi, Etelka" uniqKey="Foeldi E" first="Etelka" last="Foeldi">Etelka Foeldi</name>
<affiliation><inist:fA14 i1="02"><s1>Foeldi Clinic for Lymphology, Hinterzarten, Röβlehofweg 2-6</s1>
<s2>79856 Hinterzarten</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bartholom, Jean Paul" sort="Bartholom, Jean Paul" uniqKey="Bartholom J" first="Jean-Paul" last="Bartholom">Jean-Paul Bartholom</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Diagnostic Radiology, Department of Radiology, University Hospital of Freiburg, Hugstetter Strasse 55</s1>
<s2>79106 Freiburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Langer, Mathias" sort="Langer, Mathias" uniqKey="Langer M" first="Mathias" last="Langer">Mathias Langer</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Diagnostic Radiology, Department of Radiology, University Hospital of Freiburg, Hugstetter Strasse 55</s1>
<s2>79106 Freiburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">07-0502672</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 07-0502672 INIST</idno>
<idno type="RBID">Pascal:07-0502672</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000427</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Interstitial MR lymphangiography : A diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema</title>
<author><name sortKey="Lohrmann, Christian" sort="Lohrmann, Christian" uniqKey="Lohrmann C" first="Christian" last="Lohrmann">Christian Lohrmann</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Diagnostic Radiology, Department of Radiology, University Hospital of Freiburg, Hugstetter Strasse 55</s1>
<s2>79106 Freiburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Foeldi, Etelka" sort="Foeldi, Etelka" uniqKey="Foeldi E" first="Etelka" last="Foeldi">Etelka Foeldi</name>
<affiliation><inist:fA14 i1="02"><s1>Foeldi Clinic for Lymphology, Hinterzarten, Röβlehofweg 2-6</s1>
<s2>79856 Hinterzarten</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bartholom, Jean Paul" sort="Bartholom, Jean Paul" uniqKey="Bartholom J" first="Jean-Paul" last="Bartholom">Jean-Paul Bartholom</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Diagnostic Radiology, Department of Radiology, University Hospital of Freiburg, Hugstetter Strasse 55</s1>
<s2>79106 Freiburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Langer, Mathias" sort="Langer, Mathias" uniqKey="Langer M" first="Mathias" last="Langer">Mathias Langer</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Diagnostic Radiology, Department of Radiology, University Hospital of Freiburg, Hugstetter Strasse 55</s1>
<s2>79106 Freiburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Acta tropica</title>
<title level="j" type="abbreviated">Acta trop.</title>
<idno type="ISSN">0001-706X</idno>
<imprint><date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Acta tropica</title>
<title level="j" type="abbreviated">Acta trop.</title>
<idno type="ISSN">0001-706X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Advanced stage</term>
<term>Diagnosis</term>
<term>Evaluation</term>
<term>Human</term>
<term>Lymphedema</term>
<term>Methodology</term>
<term>Nuclear magnetic resonance imaging</term>
<term>Patient</term>
<term>Tropical medicine</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Imagerie RMN</term>
<term>Lymphoedème</term>
<term>Diagnostic</term>
<term>Méthodologie</term>
<term>Evaluation</term>
<term>Homme</term>
<term>Malade</term>
<term>Stade avancé</term>
<term>Médecine tropicale</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background: To assess the feasibility of interstitial magnetic resonance lymphangiography with intracutaneous injection of a commercially available, non-ionic, extracellular paramagnetic contrast agent, to visualize lymphatic vessels in patients with clinically advanced stages of primary lymphedema. Methods: Sixteen lower extremities in 8 patients with clinically advanced stages of primary lymphedema were examined with magnetic resonance lymphangiography. A 18 mL of gadodiamide and 2 mL of mepivacainhydrochloride 1% were subdivided into 10 portions and injected intracutaneously into the dorsal aspect of both feet. For MRL, a 3D spoiled gradient-echo sequence (Volumetric Interpolated Breathold Examination, VIBE) was performed. Results: The beaded appearance of lymphatic vessels extending from the injection site was detected in all 16 lower extremities (100%). In 10 lower extremities (63%), lymphatic vessels of the upper leg could be visualized. A contrast enhancement was observed in 10/16 inguinal lymph node groups (63%). In 12 lower extremities (75%) collateral vessels with dermal back-flow areas between lymphatic vessels were seen. Conclusion: Magnetic resonance lymphangiography is safe, technically feasible, and assists the clinician in the therapeutic planning of patients with clinically advanced stages of primary lymphedema by imaging the pathologically modified lymphatic vessels and accompanying complications non-invasively.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0001-706X</s0>
</fA01>
<fA02 i1="01"><s0>ACTRAQ</s0>
</fA02>
<fA03 i2="1"><s0>Acta trop.</s0>
</fA03>
<fA05><s2>104</s2>
</fA05>
<fA06><s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Interstitial MR lymphangiography : A diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>LOHRMANN (Christian)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>FOELDI (Etelka)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>BARTHOLOMÄ (Jean-Paul)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>LANGER (Mathias)</s1>
</fA11>
<fA14 i1="01"><s1>Division of Diagnostic Radiology, Department of Radiology, University Hospital of Freiburg, Hugstetter Strasse 55</s1>
<s2>79106 Freiburg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Foeldi Clinic for Lymphology, Hinterzarten, Röβlehofweg 2-6</s1>
<s2>79856 Hinterzarten</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA20><s1>8-15</s1>
</fA20>
<fA21><s1>2007</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>3165</s2>
<s5>354000162004620020</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2007 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>1/2 p.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>07-0502672</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Acta tropica</s0>
</fA64>
<fA66 i1="01"><s0>NLD</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Background: To assess the feasibility of interstitial magnetic resonance lymphangiography with intracutaneous injection of a commercially available, non-ionic, extracellular paramagnetic contrast agent, to visualize lymphatic vessels in patients with clinically advanced stages of primary lymphedema. Methods: Sixteen lower extremities in 8 patients with clinically advanced stages of primary lymphedema were examined with magnetic resonance lymphangiography. A 18 mL of gadodiamide and 2 mL of mepivacainhydrochloride 1% were subdivided into 10 portions and injected intracutaneously into the dorsal aspect of both feet. For MRL, a 3D spoiled gradient-echo sequence (Volumetric Interpolated Breathold Examination, VIBE) was performed. Results: The beaded appearance of lymphatic vessels extending from the injection site was detected in all 16 lower extremities (100%). In 10 lower extremities (63%), lymphatic vessels of the upper leg could be visualized. A contrast enhancement was observed in 10/16 inguinal lymph node groups (63%). In 12 lower extremities (75%) collateral vessels with dermal back-flow areas between lymphatic vessels were seen. Conclusion: Magnetic resonance lymphangiography is safe, technically feasible, and assists the clinician in the therapeutic planning of patients with clinically advanced stages of primary lymphedema by imaging the pathologically modified lymphatic vessels and accompanying complications non-invasively.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B01</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B12B04</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Imagerie RMN</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Nuclear magnetic resonance imaging</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Imaginería RMN</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Lymphoedème</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Lymphedema</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Linfedema</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Diagnostic</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Diagnosis</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Diagnóstico</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Méthodologie</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Methodology</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Metodología</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Evaluation</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Evaluation</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Evaluación</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Homme</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Human</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Hombre</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Malade</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Patient</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Enfermo</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Stade avancé</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Advanced stage</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Estadio avanzado</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Médecine tropicale</s0>
<s5>15</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Tropical medicine</s0>
<s5>15</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Medicina tropical</s0>
<s5>15</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Imagerie médicale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Medical imagery</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Imaginería médica</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Appareil circulatoire pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Lymphatique pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Linfático patología</s0>
<s5>39</s5>
</fC07>
<fN21><s1>330</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 07-0502672 INIST</NO>
<ET>Interstitial MR lymphangiography : A diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema</ET>
<AU>LOHRMANN (Christian); FOELDI (Etelka); BARTHOLOMÄ (Jean-Paul); LANGER (Mathias)</AU>
<AF>Division of Diagnostic Radiology, Department of Radiology, University Hospital of Freiburg, Hugstetter Strasse 55/79106 Freiburg/Allemagne (1 aut., 3 aut., 4 aut.); Foeldi Clinic for Lymphology, Hinterzarten, Röβlehofweg 2-6/79856 Hinterzarten/Allemagne (2 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Acta tropica; ISSN 0001-706X; Coden ACTRAQ; Pays-Bas; Da. 2007; Vol. 104; No. 1; Pp. 8-15; Bibl. 1/2 p.</SO>
<LA>Anglais</LA>
<EA>Background: To assess the feasibility of interstitial magnetic resonance lymphangiography with intracutaneous injection of a commercially available, non-ionic, extracellular paramagnetic contrast agent, to visualize lymphatic vessels in patients with clinically advanced stages of primary lymphedema. Methods: Sixteen lower extremities in 8 patients with clinically advanced stages of primary lymphedema were examined with magnetic resonance lymphangiography. A 18 mL of gadodiamide and 2 mL of mepivacainhydrochloride 1% were subdivided into 10 portions and injected intracutaneously into the dorsal aspect of both feet. For MRL, a 3D spoiled gradient-echo sequence (Volumetric Interpolated Breathold Examination, VIBE) was performed. Results: The beaded appearance of lymphatic vessels extending from the injection site was detected in all 16 lower extremities (100%). In 10 lower extremities (63%), lymphatic vessels of the upper leg could be visualized. A contrast enhancement was observed in 10/16 inguinal lymph node groups (63%). In 12 lower extremities (75%) collateral vessels with dermal back-flow areas between lymphatic vessels were seen. Conclusion: Magnetic resonance lymphangiography is safe, technically feasible, and assists the clinician in the therapeutic planning of patients with clinically advanced stages of primary lymphedema by imaging the pathologically modified lymphatic vessels and accompanying complications non-invasively.</EA>
<CC>002B01; 002B12B04</CC>
<FD>Imagerie RMN; Lymphoedème; Diagnostic; Méthodologie; Evaluation; Homme; Malade; Stade avancé; Médecine tropicale</FD>
<FG>Imagerie médicale; Appareil circulatoire pathologie; Lymphatique pathologie</FG>
<ED>Nuclear magnetic resonance imaging; Lymphedema; Diagnosis; Methodology; Evaluation; Human; Patient; Advanced stage; Tropical medicine</ED>
<EG>Medical imagery; Cardiovascular disease; Lymphatic vessel disease</EG>
<SD>Imaginería RMN; Linfedema; Diagnóstico; Metodología; Evaluación; Hombre; Enfermo; Estadio avanzado; Medicina tropical</SD>
<LO>INIST-3165.354000162004620020</LO>
<ID>07-0502672</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000427 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000427 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:07-0502672
   |texte=   Interstitial MR lymphangiography : A diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Interstitial MR lymphangiography : A diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema

Interstitial MR lymphangiography : A diagnostic imaging method for the evaluation of patients with clinically advanced stages of lymphedema

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri